Lau KY - Search Results

1

Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.

Liu CY, Huang TT, Chen YT, Chen JL, Chu PY, Huang CT, Wang WL, Lau KY, Dai MS, Shiau CW, Tseng LM. Liu CY, et al. Among authors: lau ky. EBioMedicine. 2019 Feb;40:263-275. doi: 10.1016/j.ebiom.2018.12.032. Epub 2019 Jan 14. EBioMedicine. 2019. PMID: 30651219 Free PMC article.

2

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells.

Liu CY, Huang TT, Huang CT, Hu MH, Wang DS, Wang WL, Tsai WC, Lee CH, Lau KY, Yang HP, Chen MH, Shiau CW, Tseng LM, Chen KF. Liu CY, et al. Among authors: lau ky. Eur J Cancer. 2017 Feb;72:112-123. doi: 10.1016/j.ejca.2016.11.012. Epub 2016 Dec 24. Eur J Cancer. 2017. PMID: 28027514

3

Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.

Liu CY, Su JC, Huang TT, Chu PY, Huang CT, Wang WL, Lee CH, Lau KY, Tsai WC, Yang HP, Shiau CW, Tseng LM, Chen KF. Liu CY, et al. Among authors: lau ky. Mol Oncol. 2017 Mar;11(3):266-279. doi: 10.1002/1878-0261.12033. Epub 2017 Feb 7. Mol Oncol. 2017. PMID: 28084011 Free PMC article.

4

Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.

Liu CY, Chen KF, Chao TI, Chu PY, Huang CT, Huang TT, Yang HP, Wang WL, Lee CH, Lau KY, Tsai WC, Su JC, Wu CY, Chen MH, Shiau CW, Tseng LM. Liu CY, et al. Among authors: lau ky. J Mol Med (Berl). 2017 Sep;95(9):965-975. doi: 10.1007/s00109-017-1549-x. Epub 2017 Jun 4. J Mol Med (Berl). 2017. PMID: 28578456

5

The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells.

Liu CY, Huang TT, Chu PY, Huang CT, Lee CH, Wang WL, Lau KY, Tsai WC, Chao TI, Su JC, Chen MH, Shiau CW, Tseng LM, Chen KF. Liu CY, et al. Among authors: lau ky. Exp Mol Med. 2017 Aug 11;49(8):e366. doi: 10.1038/emm.2017.114. Exp Mol Med. 2017. PMID: 28798401 Free PMC article.

6

Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.

Liu CY, Lau KY, Hsu CC, Chen JL, Lee CH, Huang TT, Chen YT, Huang CT, Lin PH, Tseng LM. Liu CY, et al. Among authors: lau ky. PLoS One. 2017 Dec 20;12(12):e0189007. doi: 10.1371/journal.pone.0189007. eCollection 2017. PLoS One. 2017. PMID: 29261702 Free PMC article.

7

SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment.

Huang YH, Chu PY, Chen JL, Huang CT, Lee CH, Lau KY, Wang WL, Wang YL, Lien PJ, Tseng LM, Liu CY. Huang YH, et al. Among authors: lau ky. J Clin Med. 2018 Aug 28;7(9):245. doi: 10.3390/jcm7090245. J Clin Med. 2018. PMID: 30154367 Free PMC article.

8

Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells.

Liu CY, Chu PY, Huang CT, Chen JL, Yang HP, Wang WL, Lau KY, Lee CH, Lan TY, Huang TT, Lin PH, Dai MS, Tseng LM. Liu CY, et al. Among authors: lau ky. Cancers (Basel). 2019 Jan 17;11(1):105. doi: 10.3390/cancers11010105. Cancers (Basel). 2019. PMID: 30658422 Free PMC article.

9

Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.

Huang TT, Tseng LM, Chen JL, Chu PY, Lee CH, Huang CT, Wang WL, Lau KY, Tseng MF, Chang YY, Chiang TY, Ueng YF, Lee HC, Dai MS, Liu CY. Huang TT, et al. Among authors: lau ky. EBioMedicine. 2020 Apr;54:102717. doi: 10.1016/j.ebiom.2020.102717. EBioMedicine. 2020. PMID: 32268268 Free PMC article.

10

Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model.

Tseng LM, Lau KY, Chen JL, Chu PY, Huang TT, Lee CH, Wang WL, Chang YY, Huang CT, Huang CC, Chao TC, Tsai YF, Lai JI, Dai MS, Liu CY. Tseng LM, et al. Among authors: lau ky. Exp Cell Res. 2023 Aug 1;429(1):113652. doi: 10.1016/j.yexcr.2023.113652. Epub 2023 May 18. Exp Cell Res. 2023. PMID: 37209991 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters